ArticleCancer management and research2020

Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway.

Haoyue Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.